beta-1,3-N-Acetylgalactosaminyl Transferase 2 (B3GALNT2) (Middle Region) Peptide
B3GALNT2
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN973676
150,78 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 15 à 21 jours ouvrables
Aperçu rapide pour beta-1,3-N-Acetylgalactosaminyl Transferase 2 (B3GALNT2) (Middle Region) Peptide (ABIN973676)
Antigène
B3GALNT2
(beta-1,3-N-Acetylgalactosaminyl Transferase 2 (B3GALNT2))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-B3GALNT2 antibody (Catalog #: ARP49061_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- B3GALNT2 (beta-1,3-N-Acetylgalactosaminyl Transferase 2 (B3GALNT2))
-
Sujet
-
B3GALNT2 is the beta-1,3-N-acetylgalactosaminyltransferase active in synthesizing a unique carbohydrate structure, GalNAc-beta-1-3GlcNAc, on N- and O-glycans. B3GALNT2 has no galactose nor galactosaminyl transferase activity toward any acceptor substrate.
Alias Symbols: B3GalNAc-T2, MGC39558
Protein Size: 500 -
Poids moléculaire
- 57 kDa
-
ID gène
- 148789
-
NCBI Accession
- NM_152490, NP_689703
-
UniProt
- Q8NCR0
Antigène
-
Vous êtes ici:
